Pharma Industry News

GSK announces positive real world data for Nucala

The study is the first prospective global real-world study of a biologic treatment in patients with severe eosinophilic asthma.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]